Pharmacists

• 

  Subject Areas on Research

  • A Pharmacy-Based Electronic Handoff Tool to Reduce Discharge Prescribing of Atypical Antipsychotics Initiated in the Intensive Care Unit: A Quality Improvement Initiative. 
  • A method for assessing drug therapy appropriateness. 
  • Antimicrobial stewardship programs: how to start and steer a successful program. 
  • Assessing feasibility of delivering pharmacogenetic testing in a community pharmacy setting. 
  • Assessing safety culture in pharmacies: the psychometric validation of the Safety Attitudes Questionnaire (SAQ) in a national sample of community pharmacies in Sweden. 
  • Availability and use of essential medicines in China: manufacturing, supply, and prescribing in Shandong and Gansu provinces. 
  • Benefits and drawbacks to hormone replacement therapy among nursing home patients. 
  • Clinical delivery of pharmacogenetic testing services: a proposed partnership between genetic counselors and pharmacists. 
  • Community pharmacists' experience with pharmacogenetic testing. 
  • Comparison of delivery strategies for pharmacogenetic testing services. 
  • Demonstrating mutagenicity using the Ames test. 
  • Does the presence of a pharmacist in primary care clinics improve diabetes medication adherence? 
  • Effect of Medicaid Policy Changes on Medication Adherence: Differences by Baseline Adherence. 
  • Essential Resources and Strategies for Antibiotic Stewardship Programs in the Acute Care Setting. 
  • Establishing an Antimicrobial Stewardship Collaborative Across a Large, Diverse Health Care System. 
  • Evaluation of the effectiveness of UK community pharmacists' interventions in community palliative care. 
  • Exploratory planning and implementation of a pilot pharmacogenetic program in a community pharmacy. 
  • Factors affecting Medicare Part D beneficiaries' decision to receive comprehensive medication reviews. 
  • Feasibility of Core Antimicrobial Stewardship Interventions in Community Hospitals. 
  • Health care providers' use of a drug information service for pregnancy-related inquiries. 
  • Hospital administrators' perceptions of pharmacy directors. 
  • Implementation of a pharmacogenomics service in a community pharmacy. 
  • Improving blood pressure control through a clinical pharmacist outreach program in patients with diabetes mellitus in 2 high-performing health systems: the adherence and intensification of medications cluster randomized, controlled pragmatic trial. 
  • Improving care transitions: current practice and future opportunities for pharmacists. 
  • Incidence of Drug Interactions Identified by Clinical Pharmacists in Veterans Initiating Treatment for Chronic Hepatitis C Infection. 
  • Influence of Successful Chronic Hepatitis C Virus Treatment with Ledipasvir/Sofosbuvir on Warfarin Dosing Requirements in Four Veterans. 
  • Influence of time stress and other variables on counseling by pharmacists about antiretroviral medications. 
  • Management of Idiopathic Pulmonary Fibrosis. 
  • Medication Use Quality and Safety in Older Adults: 2018 Update. 
  • Medication errors in hospitalized cardiovascular patients. 
  • Medication misadventures in older adults: literature from 2013. 
  • Meta-analysis of Interventions to Reduce Adverse Drug Reactions in Older Adults. 
  • New models of chronic kidney disease care including pharmacists: improving medication reconciliation and medication management. 
  • North Carolina Medicaid recipient management lock-in program: the pharmacist's perspective. 
  • Patient safety-focused medication therapy management: challenges affecting future implementation. 
  • Patient-focused intervention to improve long-term adherence to evidence-based medications: a randomized trial. 
  • Patient-reported medication adherence barriers among patients with cardiovascular risk factors. 
  • Patients' perceptions of the benefits of pharmaceutical care. 
  • Pharmacist prescription of hormonal contraception in Oregon: Baseline knowledge and interest in provision. 
  • Pharmacist-managed antimicrobial stewardship program for patients discharged from the emergency department. 
  • Pharmacist-managed international normalized ratio patient self-testing is associated with increased time in therapeutic range in patients with left ventricular assist devices at an academic medical center. 
  • Pharmacists as health educators and risk communicators in the early detection of prostate cancer. 
  • Pharmacists' attitudes toward dispensing naloxone and medications for opioid use disorder: A scoping review of the literature. 
  • Pharmacists' experience with prescribing hormonal contraception in Oregon. 
  • Pharmacists' knowledge of infusion devices. 
  • Physician agreement with pharmacist-suggested drug therapy changes for elderly outpatients. 
  • Pilot study of pharmacist-assisted delivery of pharmacogenetic testing in a primary care setting. 
  • Practitioner acceptance of the dofetilide risk-management program. 
  • Prescriptions for justice: using social accounts to legitimate the exercise of professional control. 
  • Primary care providers' use of pharmacist support for delivery of pharmacogenetic testing. 
  • Proposal for a pharmacogenetics certificate program for pharmacists. 
  • Racial Differences in the Effectiveness of a Multifactorial Telehealth Intervention to Slow Diabetic Kidney Disease. 
  • Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team: results of the Pharmacist in Heart Failure Assessment Recommendation and Monitoring (PHARM) Study. 
  • Regarding Collaboration in Antimicrobial Stewardship. 
  • Reliability of drug utilization evaluation as an assessment of medication appropriateness. 
  • Role orientation and community pharmacists' participation in a project to improve patient care. 
  • Study protocol: the Adherence and Intensification of Medications (AIM) study--a cluster randomized controlled effectiveness study. 
  • Telemedicine cardiovascular risk reduction in veterans. 
  • The Cardiovascular Intervention Improvement Telemedicine Study (CITIES): rationale for a tailored behavioral and educational pharmacist-administered intervention for achieving cardiovascular disease risk reduction. 
  • The Role of Pharmacists in the Opioid Epidemic: An Examination of Pharmacist-Focused Initiatives Across the United States and North Carolina. 
  • The cost-effectiveness of a clinical pharmacist intervention among elderly outpatients. 
  • The hypertension team: the role of the pharmacist, nurse, and teamwork in hypertension therapy. 
  • The utilization of video-conference shared medical appointments in rural diabetes care. 
  • Use of bupropion SR in a pharmacist-managed outpatient smoking-cessation program. 
  • Worldwide Organization of Neurocritical Care: Results from the PRINCE Study Part 1. 
• 

  Keywords of People

  • O'Connor, Christopher Michael, Richard Sean Stack, M.D. Distinguished Professor, Medicine, Clinical Pharmacology
  • Olsen, Maren Karine, Professor of Biostatistics and Bioinformatics, Biostatistics & Bioinformatics
  • Patel, Uptal Dinesh, Adjunct Professor in the Department of Medicine, Medicine, Nephrology